Drugs / Depot leuprolide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00203996 | Sep 2003 → Jun 2008 | obstructive sleep apnea syndrome, polycystic ovary syndrome | University of Chicago | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Depot leuprolide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00203996 ↗ |
| Action | Inhibit | “This study drug will temporarily reduce the pituitary hormones that stimulate the ovaries to make both female (estrogen) and male (testosterone) hormones.” NCT00203996 ↗ |